aTYR PHARMA ATYR
NASDAQ ATYR
$0.50 0.00 (-0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Capital Expenditures (2014 - 2026)

aTYR PHARMA's (ATYR) quarterly Capital Expenditures came in at $138000.0 in Q1 2026, up 345.16% on a QoQ basis from $31000.0 in Q4 2025.

aTYR PHARMA (ATYR) Capital Expenditures (2014 - 2026) Analysis & Trends

aTYR PHARMA (ATYR) has 13 years of Capital Expenditures data on file, last reported at $138000.0 in Q1 2026.

  • Quarterly Capital Expenditures changed N/A year-over-year to $138000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215000.0 (up 347.92% YoY) and the FY2025 annual result came in at $77000.0, up 18.46% from the prior year.
  • Capital Expenditures improved to $138000.0 in Q1 2026, from $31000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.4 million in Q2 2023 to a low of $8000.0 in Q2 2024.
  • A 5-year average of $383500.0 and a median of $40000.0 in 2022 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2022 — Capital Expenditures surged 6116.67% — and 2024, when it sank 99.67%.
  • Tracing ATYR's Capital Expenditures over 5 years: stood at $1.1 million in 2022, then tumbled by 98.48% to $17000.0 in 2023, then soared by 47.06% to $25000.0 in 2024, then grew by 24.0% to $31000.0 in 2025, then soared by 345.16% to $138000.0 in 2026.
  • The last three Capital Expenditures figures came in at $138000.0 (Q1 2026), $31000.0 (Q4 2025), and $37000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 25.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 34.68 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -73.57 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.26 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 251.02 Mn
10 aTYR PHARMA 49.54 Mn -7.87 Mn - 73,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 73,000.00
Jun 30, 2026 73,000.00
Mar 31, 2026 138,000.00
Mar 31, 2026 138,000.00
Dec 31, 2025 31,000.00
Dec 31, 2025 31,000.00
Sep 30, 2025 37,000.00
Sep 30, 2025 37,000.00
Jun 30, 2025 9,000.00
Jun 30, 2025 9,000.00
Dec 31, 2024 25,000.00
Dec 31, 2024 25,000.00
Sep 30, 2024 15,000.00
Sep 30, 2024 15,000.00
Jun 30, 2024 8,000.00
Jun 30, 2024 8,000.00
Mar 31, 2024 17,000.00
Mar 31, 2024 17,000.00
Dec 31, 2023 17,000.00
Dec 31, 2023 17,000.00